Skip to content

Effect of Portulaca oleracea on primary insomnia

Evaluation of the possible hypnotic impact of Portulaca oleracea made product on patients suffering from primary insomnia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180103038199N2
Enrollment
70
Registered
2020-08-06
Start date
2020-08-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary insomnia. Primary insomnia

Interventions

Intervention 1: Control group: receiving the same form of capsule prepared from Portulaca oleracea extract with starch powder without basil in the form of 500 mg unique shapes for all groups. It is no

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: primary sleep disorders Willing to cooperate Defined conditions of initial insomnia according to DSM-V Symptoms for at least three months Lack of illnesses such as pulmonary diseases, allergic rhinitis, heart disease, infectious diseases, cancers Lack of Mental Illness: Like Depression No neurological disease like Parkinson's, Alzheimer's Lack of sleep disorders such as sleep apnea

Exclusion criteria

Exclusion criteria: Pregnant and lactating women History of allergy to medicinal herbs Unwillingness to cooperation for any reason

Design outcomes

Primary

MeasureTime frame
Changing the score in the Pittsburgh Questionnaire. Timepoint: Before the beginning of the study and at the end of the study. Method of measurement: Based on the Pittsburgh Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hassan Rakhshandeh

Mashhad University of Medical Sciences

rakhshandehh@mums.ac.ir+98 915 503 6929

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026